WCN26-7656 IgA Vasculitis Associated With MASH-Related Cirrhosis: Clinical Implications for Steroid Use in Metabolic Liver Disease

Read full text Summarise with VIRAT
Authors: Chikara Asai, Naoki Kamegai, Michiya Ohno, Junichiro Yamamoto
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

While cirrhosis-associated IgA nephropathy has been well documented, systemic IgA vasculitis (IgAV) developing in this context is extremely uncommon. Among the various etiologies of cirrhosis, metabolic dysfunction–associated steatohepatitis (MASH) represents a distinct metabolic phenotype induced by chronic inflammation, and only a few IgA-related kidney or vasculitic diseases have been described in this setting. We report a rare case of biopsy-proven IgAV occurring in a patient with MASH-related cirrhosis, resulting in hepatic decompensation after corticosteroid therapy.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Vasculitis and related conditions Liver Disease and Transplantation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104532–104532
Publication date
25 March 2026
Language
EN